

International outcomes in breast, cervical, and ovarian cancers highlight opportunities to improve health-care delivery for women at all economic levels. In high-income countries (HICs), early detection programmes, timely diagnosis, and access to cancer treatment to completion have led to considerable improvements in cancer survival. These successes, however, are yet to be realised in most low-income and middle-income countries (LMICs).
General Medicine
|15th Jan, 2026
|The Lancet
General Medicine
|15th Jan, 2026
|The Lancet
General Medicine
|15th Jan, 2026
|The Lancet
General Medicine
|15th Jan, 2026
|The Lancet
General Medicine
|15th Jan, 2026
|The Lancet
General Medicine
|15th Jan, 2026
|The Lancet
General Medicine
|15th Jan, 2026
|The Lancet